Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of NEXLETOL® tablets in diverse populations.
Esperion Therapeutics shares climbed 7.1% to $3.47 pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Longeveron Inc. (NASDAQ: LGVN) rose 93.2% to $4.25 in pre-market trading after gaining 8% on Friday.
- Antelope Enterprise Holdings Limited (NASDAQ: AEHL) shares rose 47% to $2.20 in pre-market trading after declining 5% on Friday. On April 1, Antelope Enterprise announced preliminary full year 2023 revenue of $70.4 million.
- DigiAsia Corp. (NASDAQ: FAAS) shares rose 31.6% to $8.46 in pre-market trading after the jumping around 17% on Friday.
- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) gained 27.2% to $1.31 in pre-market trading.
- Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 25.6% to $0.2840 in pre-market trading after dipping over 8% on ...